TY  - GEN
AU  - Islam,M Ashequl
AU  - Blankenship,James C
AU  - Balog,Craig
AU  - Iliadis,Elias A
AU  - Lincoff,A Michael
AU  - Tcheng,James E
AU  - Califf,Robert M
AU  - Topol,Eric J
TI  - Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)
SN  - 0002-9149
PY  - 2002///1209
KW  - Abciximab
KW  - Angioplasty, Balloon, Coronary
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Blood Vessel Prosthesis Implantation
KW  - Coronary Angiography
KW  - adverse effects
KW  - Creatine Kinase
KW  - blood
KW  - Creatine Kinase, MB Form
KW  - Double-Blind Method
KW  - Drug Evaluation
KW  - Endpoint Determination
KW  - Female
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Incidence
KW  - Isoenzymes
KW  - Male
KW  - Myocardial Ischemia
KW  - epidemiology
KW  - North America
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - Stents
KW  - Survival Analysis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0002-9149(02)02653-x
ER  -